Internal Medicine Department, Faculty of Medicine, Federal University of Mato Grosso, Cuiabá, Mato Grosso, Brazil; Júlio Muller University Hospital, Federal University of Mato Grosso, Cuiabá, Mato Grosso, Brazil.
Laboratory of Emerging Fungal Pathogens, Department of Microbiology, Immunology and Parasitology, Federal University of São Paulo, São Paulo, Brazil; Discipline of Infectious Diseases, Department of Medicine, Federal University of São Paulo, São Paulo, Brazil.
Int J Infect Dis. 2021 Jun;107:284-290. doi: 10.1016/j.ijid.2021.05.002. Epub 2021 May 12.
Historically, the Brazilian Central-West region has had high numbers of paracoccidioidomycosis (PCM) cases caused by the dimorphic fungus Paracoccidioides lutzii.
This epidemiological, observational, analytical, cross-sectional study was performed to investigate the clinical and laboratory data of 44 PCM patients with a culture-proven P. lutzii infection. All patients were referred to the Systemic Mycosis Center, Júlio Muller University Hospital, Cuiabá, Brazil, during January 2017 to March 2020. The neutrophil to lymphocyte ratio (NLR) was calculated and dichotomized by its median value to include in the identification of factors associated with severity.
At admission, 13 (31.7%) patients showed the disseminated multifocal chronic form of PCM and 16 (36.4%) patients met the clinical severity criteria. Treatment prescribed on admission did not follow the recommendations of the Brazilian Guideline for the Clinical Management of Paracoccidioidomycosis in 26% of the severe PCM cases (prevalence ratio 0.26, 95% confidence interval 0.14-0.49; P < 0.0001). Patients with severe PCM had a higher NLR that was greater than the median (≥4.11).
The NLR biomarker complements the criteria for PCM severity. Applying the low-cost NLR test can greatly increase the diagnostic sensitivity when screening patients for PCM and contribute to better control of the disease, management of complications, and therapeutic strategies.
历史上,巴西中西部地区的荚膜组织胞浆菌病(PCM)病例数量较多,这些病例由双相真菌巴西副球孢子菌引起。
本研究为一项流行病学、观察性、分析性、横断面研究,目的是调查 44 例经培养证实为巴西副球孢子菌感染的 PCM 患者的临床和实验室数据。所有患者于 2017 年 1 月至 2020 年 3 月期间被转诊至巴西库亚巴朱利奥·穆勒大学医院系统性真菌病中心。计算中性粒细胞与淋巴细胞比值(NLR),并根据中位数将其分为两部分,以确定与严重程度相关的因素。
入院时,13 例(31.7%)患者表现为播散性多灶性慢性 PCM 形式,16 例(36.4%)患者符合临床严重程度标准。在 26%的严重 PCM 病例中(比值比 0.26,95%置信区间 0.14-0.49;P<0.0001),入院时开具的治疗方案并未遵循巴西荚膜组织胞浆菌病临床管理指南的建议。严重 PCM 患者的 NLR 高于中位数(≥4.11)。
NLR 生物标志物补充了 PCM 严重程度的标准。应用低成本的 NLR 检测可以极大地提高 PCM 患者筛查的诊断灵敏度,并有助于更好地控制疾病、管理并发症和治疗策略。